immUni Technology Overview
- Headquarters
- Ch
- Website
- immuni.ch
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About immUni Technology
Our technology uniquely combines biochemical and physical stimulation of immune cells. This innovative way of activating immune cells contributes to a significant enhancement of current therapeutic cell production steps, leading to shorter production time and better end product characteristics. ImmUni is committed to deliver a unique technology to advance cell therapies for benefit of the patients.
Compare Similar Companies to immUni Technology
Virometix AG
Biotechnology Research
PreComb
Biotechnology Research
Bucher Biotec AG
Biotechnology Research
arcoris bio AG
Biotechnology Research
CELLEC Biotek AG
Biotechnology Research
Evax AG
Biotechnology Research
CanVirex
Biotechnology Research
Selectoprobe
Medical And Diagnostic Laboratories
Eaglenos Sciences (Switzerland)
Biotechnology Research
Ectica Technologies
Biotechnology Research